Evidence map›Paper›PMID 25352811›Full record

ArticleFrontiers in psychiatry2014

The auditory brain-stem response to complex sounds: a potential biomarker for guiding treatment of psychosis.

Melissa A Tarasenko, Neal R Swerdlow, Scott Makeig, David L Braff, Gregory A Light

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Trial
  2. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  3. Review
  4. Article
  5. Article
  6. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  7. Review
  8. Article
  9. Research Review: Use of EEG biomarkers in child psychiatry research - current state and future directions.Journal of child psychology and psychiatry, and allied disciplines · 2016
    Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Melissa A TarasenkoVISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System , La Jolla, CA , USA ; Department of Psychiatry, University of California San Diego , La Jolla, CA , USA.
Neal R SwerdlowDepartment of Psychiatry, University of California San Diego , La Jolla, CA , USA.
Scott MakeigSwartz Center for Computational Neuroscience, Institute for Neural Computation, University of California San Diego , La Jolla, CA , USA.
David L BraffVISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System , La Jolla, CA , USA ; Department of Psychiatry, University of California San Diego , La Jolla, CA , USA.
Gregory A LightVISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System , La Jolla, CA , USA ; Department of Psychiatry, University of California San Diego , La Jolla, CA , USA.
University of California, San Diego · USMental Illness Research, Education and Clinical Centers · USVA San Diego Healthcare System · US

Funding

San Diego Clinical and Translational Research InstituteUL1TR000100 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2012 to 2015
$19.7M
Accelerated Inflammaging in SchizophreniaR01MH094151 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI EYLER, LISA T · 2012 to 2021
$7.4M
The Genetics of Endophenotypes and SchizophreniaR01MH065571 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRAFF, DAVID L. · 2003 to 2013
$7.0M
SENSORY GATING &HABITUATION IN SCHIZOPHRENIAR01MH042228 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRAFF, DAVID L. · 1987 to 2015
$6.5M
6/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081944 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CADENHEAD, KRISTIN S. · 2008 to 2018
$4.9M
Pharmacologic augmentation of neurocognition and cognitive training in psychosisR01MH059803 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SWERDLOW, NEAL R · 1999 to 2018
$4.5M
Memantine effects on sensorimotor gating and neurocognition in schizophreniaR01MH094320 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SWERDLOW, NEAL R · 2012 to 2020
$2.6M
SENSORY GATING AND HABITUATION IN SCHIZOPHRENIAR37MH042228 · NIMH · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI BRAFF, DAVID L. · 1993 to 2002
$1.3M
Biomarker Strategies for Medication-Enhanced Cognitive Training in SchizophreniaR34MH093453 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SWERDLOW, NEAL R · 2011 to 2013
$689k
NCATS NIH HHS UL1 TR000100NIMH NIH HHS R01 MH042228NIMH NIH HHS R01 MH059803NIMH NIH HHS R01 MH065571NIMH NIH HHS R01 MH094151NIMH NIH HHS R01 MH094320NIMH NIH HHS R34 MH093453NIMH NIH HHS R37 MH042228NIMH NIH HHS U01 MH081944
6 · The paper itself

Abstract

Cognitive deficits limit psychosocial functioning in schizophrenia. For many patients, cognitive remediation approaches have yielded encouraging results. Nevertheless, therapeutic response is variable, and outcome studies consistently identify individuals who respond minimally to these interventions. Biomarkers that can assist in identifying patients likely to benefit from particular forms of cognitive remediation are needed. Here, we describe an event-related potential (ERP) biomarker - the auditory brain-stem response (ABR) to complex sounds (cABR) - that appears to be particularly well-suited for predicting response to at least one form of cognitive remediation that targets auditory information processing. Uniquely, the cABR quantifies the fidelity of sound encoded at the level of the brainstem and midbrain. This ERP biomarker has revealed auditory processing abnormalities in various neurodevelopmental disorders, correlates with functioning across several cognitive domains, and appears to be responsive to targeted auditory training. We present preliminary cABR data from 18 schizophrenia patients and propose further investigation of this biomarker for predicting and tracking response to cognitive interventions.

Indexed as

auditory brain-stem responsebiomarkerscognitive remediationcomplex auditory brain-stem responseEEGpsychosisschizophrenia

Identifiers

PMID25352811
PMCPMC4195270
OpenAlexW1970883379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.